136 related articles for article (PubMed ID: 6974631)
1. [Treatment of malignant neoplasms in advanced stages with HDMTX-CF Rescue (high-dose methotrexate-citrovorum factor rescue)].
Paparopoli G; Agostara B; Di Girolamo G
Clin Ter; 1981 May; 97(3):271-81. PubMed ID: 6974631
[No Abstract] [Full Text] [Related]
2. [Therapy of solid tumors using high-dose methotrexate and citrovorum factor].
Baumgartner G; Heinz R; Karrer K; Pridun N; Lutz D
Osterr Z Onkol; 1977; 3(5-6):141-8. PubMed ID: 300863
[TBL] [Abstract][Full Text] [Related]
3. Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue.
Isacoff WH; Eilber F; Tabbarah H; Klein P; Dollinger M; Lemkin S; Sheehy P; Cone L; Rosenbloom B; Sieger L; Block JB
Cancer Treat Rep; 1978 Sep; 62(9):1295-304. PubMed ID: 356984
[TBL] [Abstract][Full Text] [Related]
4. [High-dose methotrexate with citrovorum factor rescue in the treatment of malignant tumors (author's transl)].
Wang QL; Sun Y; Zhou JC; Song SZ; Lu L; Ye ZS
Zhonghua Zhong Liu Za Zhi; 1979; 1(2):144-9. PubMed ID: 317948
[No Abstract] [Full Text] [Related]
5. High-dose methotrexate-citrovorum factor rescue in the management of brain tumors.
Djerassi I; Kim JS; Shulman K
Cancer Treat Rep; 1977 Jul; 61(4):691-4. PubMed ID: 301782
[No Abstract] [Full Text] [Related]
6. [Phase II trial of high dose methotrexate with citrovorum factor "rescue" for hematological malignancies].
Ueda T; Kubota Y; Saigo K; Tanaka T; Takubo T; Shibata H; Nakamura H; Masaoka T; Yoshitake J; Ishigami S
Rinsho Ketsueki; 1982 Jun; 23(6):854-61. PubMed ID: 6983592
[No Abstract] [Full Text] [Related]
7. [Effects of a massive dosage of methotrexate and leucovorin rescue therapy on acute leukemia and malignant lymphoma].
Gan To Kagaku Ryoho; 1982 Mar; 9(3):421-32. PubMed ID: 6764106
[TBL] [Abstract][Full Text] [Related]
8. [High-dose methotrexate with citrovorum factor rescue in osteogenic carcinoma].
Levi M; Sulkes A; Katz E; Rizel S; Biran S
Harefuah; 1980 Sep; 99(5-6):110-3. PubMed ID: 6970707
[No Abstract] [Full Text] [Related]
9. Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration.
Von Hoff DD; Penta JS; Helman LJ; Slavik M
Cancer Treat Rep; 1977 Jul; 61(4):745-8. PubMed ID: 301783
[TBL] [Abstract][Full Text] [Related]
10. [Effect of methotrexate-citrovorum factor (MTX-CF) rescue therapy in a case of malignant histiocytosis with disseminated intravascular coagulation (author's transl)].
Fukuhara S; Kim R; Aoki Y; Okada S; Yoneda M; Kita K; Nasu K; Tatsumi E; Shirakawa S; Uchino H
Rinsho Ketsueki; 1981 Jul; 22(7):1145-51. PubMed ID: 6977047
[No Abstract] [Full Text] [Related]
11. A clinical and pharmacological study of high-dose methotrexate with minimal leucovorin rescue.
Stoller RG; Kaplan HG; Cummings FJ; Calabresi P
Cancer Res; 1979 Mar; 39(3):908-12. PubMed ID: 311683
[No Abstract] [Full Text] [Related]
12. High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.
Nirenberg A; Mosende C; Mehta BM; Gisolfi AL; Rosen G
Cancer Treat Rep; 1977 Aug; 61(5):779-83. PubMed ID: 302143
[No Abstract] [Full Text] [Related]
13. Selected applications of methotrexate alone and in combination in osteosarcoma.
Pratt CB
Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
[TBL] [Abstract][Full Text] [Related]
14. [High dose of methotrexate-leucovorin treatment in advanced non-Hodgkin's lymphoma].
Kawarabayashi K; Yoshikawa T; Sannomiya Y; Hashimoto K; Araki J; Park K; Tatumi Y; Kamitani T; Im T; Tatumi N
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2493-9. PubMed ID: 6606395
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of citrovorum factor and carboxypeptidase G1 on cerebrospinal fluid-methotrexate pharmacokinetics.
Abelson HT; Ensminger W; Rosowsky A; Uren J
Cancer Treat Rep; 1978 Oct; 62(10):1549-52. PubMed ID: 309355
[TBL] [Abstract][Full Text] [Related]
16. [High dose methotrexate with leucovorin rescue in the treatment of malignant lymphoma].
Sampi K; Hattori M
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1068-73. PubMed ID: 6985194
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.
Barlow JJ; Piver MS
Cancer Treat Rep; 1976 May; 60(5):527-33. PubMed ID: 1086714
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pharmacological studies of methotrexate-minimal leucovorin rescue plus fluorouracil.
Wiemann MC; Cummings FJ; Kaplan HG; Spremulli EN; Doolittle CH; Calabresi P
Cancer Res; 1982 Sep; 42(9):3896-900. PubMed ID: 6980707
[No Abstract] [Full Text] [Related]
20. High-dose methotrexate with leucovorin rescue.
Akahoshi M
Cancer Nurs; 1978 Aug; 1(4):319-25. PubMed ID: 307982
[No Abstract] [Full Text] [Related]
[Next] [New Search]
